Multiple reports say regulators are taking action relating to “DIY Ozempic” products sold through a business described as Supreme Peptides, with concerns raised about unlicensed supply and safety.
The coverage centers on Anthony Fowler, described as an ex-Olympic boxer and influencer, who is reported to have promoted or sold the products. The articles also point to a London-based lab described as “mystery,” raising questions about sourcing and oversight. Scientists and other experts cited across the reports say the risk comes from selling medicines outside approved channels, with uncertainties about what is actually contained in the products and how they are produced and distributed.
The outlets also describe regulators as “cracking down,” characterizing Fowler as a repeat offender. While the reporting largely focuses on potential dangers to consumers and the enforcement response, it does not provide a consistent set of specific legal charges or outcomes in the material provided. Overall, the shared theme is concern over the sale of unlicensed weight-loss injections and the enforcement effort to reduce harm.
